ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Paul W.M. Fedak
Richard D. Weisel
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fedak, P. W.M.
Right arrow Articles by Weisel, R. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fedak, P. W.M.
Right arrow Articles by Weisel, R. D.
Related Collections
Right arrow Myocardial protection

Ann Thorac Surg 2002;74:2160
© 2002 The Society of Thoracic Surgeons

Invited commentary

Paul W.M. Fedak, MDa, Nick Mamalias, MSa, Richard D. Weisel, MDa

a Toronto General Hospital, Division of Cardiac Surgery, 200 Elizabeth Street EN 14-215 Toronto, Ontario M5G 2C4 Canada

The first 20% of the full text of this article appears below.

Falcoz and colleagues performed a prospective randomized trial evaluating myocardial protection in patients undergoing primary elective coronary bypass surgery. They found no difference between warm and tepid blood cardioplegia. In these low-risk patients, both types of cardioplegia provided excellent protection. A larger study for the inclusion of high-risk patients would . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.